Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06505148 · ClinicalTrials.gov registry record · Phase 4

Comparing the Difference in Pain Control in the Pediatric General Surgery Population: to Alternate or Combine Acetaminophen and Ibuprofen?

A Phase 4 study, sponsored by Baylor Research Institute.

Not yet
Registry status
Phase 4
Development phase
80
Enrollment target

NCT06505148 is a Phase 4 study that has not yet begun recruiting, run by Baylor Research Institute. The registered enrollment target is 80 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06505148, a Phase 4 study, has not yet begun recruiting, sponsored by Baylor Research Institute.

NOT YET RECRUITING
Registry status
Phase 4
Development phase
80 participants
Enrollment target

Study Summary

To examine the difference in pain control in the pediatric general surgery population alternating acetaminophen and Ibuprofen q 3 hours vs giving them simultaneous combination therapy around the clock.

Interventions

  • DRUG Acetaminophen
  • DRUG Ibuprofen

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2024-08-01
Est. Completion 2025-08-01
Phase Phase 4

Sponsor

Baylor Research Institute

180 total trials

What the Registry Record Tells You About NCT06505148

The ClinicalTrials.gov registry entry for NCT06505148 describes a study currently listed as not yet recruiting, categorized as Phase 4. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor Research Institute, which has 180 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Acetaminophen is the first listed.

NCT06505148 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06505148 about?

NCT06505148 is a clinical study titled "Comparing the Difference in Pain Control in the Pediatric General Surgery Population: to Alternate or Combine Acetaminophen and Ibuprofen?". To examine the difference in pain control in the pediatric general surgery population alternating acetaminophen and Ibuprofen q 3 hours vs giving them simultaneous combination therapy around the clock.

What is the current status of trial NCT06505148?

This trial is currently not yet recruiting. It is a Phase 4 study. The enrollment target is 80 participants. The study started on 2024-08-01. Estimated completion is 2025-08-01.

What interventions are being tested in trial NCT06505148?

The interventions under investigation include: Acetaminophen (DRUG), Ibuprofen (DRUG).

Who is sponsoring clinical trial NCT06505148?

This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.